
MAA Laboratories, based in Durham, NC, specializes in developing nano drug delivery technology for advanced medicines.
MAA Laboratories, founded in 2013 and headquartered in Durham, North Carolina, is a specialty pharmaceutical company focused on developing advanced nano drug delivery technology. Their core mission is to revolutionize the pharmaceutical industry by creating more effective and efficient nano-formulated medicines. The company's flagship product is the NanoCont™ drug development platform, designed to address a wide range of drug delivery and development challenges. MAA Laboratories primarily targets the pharmaceutical market, aiming to enhance the efficacy and safety of medications.
Notable individuals affiliated with MAA Laboratories include experts in pharmaceutical sciences and nanotechnology, although specific names are not provided. The company has attracted interest from investors focused on cutting-edge medical technologies. Key achievements include the successful development and application of their NanoCont™ platform, which has shown promise in improving drug delivery outcomes. Overall, MAA Laboratories has made a significant impact on the pharmaceutical industry by pushing the boundaries of traditional drug formulation and delivery methods.
Companies similar to MAA Laboratories include Nanocopoeia, NanoPharmaceuticals, Maia Pharmaceuticals and Advanced NanoTherapies.
MAA Laboratories was founded in 2013.
MAA Laboratories' headquarters is located in Durham, NC, US.
MAA Laboratories' most recent funding round was for $225k (USD) in June 2017.
As of Jun 9, 2017, MAA Laboratories has raised a total of $225k (USD).
MAA Laboratories has 17 employees as of Feb 4, 2024.
Maia Pharmaceuticals
maiapharma.com